Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares conducted on April 14, 2026. The filing covers the month of April 2026 and details a share repurchase executed through BNP Paribas SA as part of an existing buyback programme announced on February 17, 2026.
Key Financial Metrics
- Shares Purchased: 325,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 2,164.00p; highest price paid was 2,194.00p.
- Average Price: Volume-weighted average price paid was 2,176.46p.
- Treasury Holdings: Following this purchase, GSK holds 258,762,615 ordinary shares in treasury.
- Shares in Issue: 4,057,428,154 ordinary shares (excluding treasury shares).
- Voting Rights: Treasury shares represent 6.38% of total voting rights.
Material Changes
Since the commencement of the current buyback programme on February 17, 2026, GSK has purchased a total of 18,871,521 ordinary shares. The April 14 transaction increased the treasury share count and reduced the number of shares in issue. The filing does not provide comparative financial data (revenue, profit, or cash flow) for the period, as it is a transaction-specific report rather than a financial results announcement.
Outlook, Risks, and Commentary
The purchased shares are held as Treasury shares. Management confirms the transaction was effected pursuant to a non-discretionary agreement with the broker. The filing includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in the "Risk Factors" section of GSK's Annual Report on Form 20-F for 2025. No specific guidance or new risk factors were introduced in this document.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback programme since February 17, 2026 (18,871,521).
- Confirm the updated treasury share count (258,762,615) and its impact on voting rights (6.38%).
- Review the volume-weighted average price (2,176.46p) against prevailing market prices on April 14, 2026.
- Check the remaining capacity or duration of the buyback programme announced in February 2026.